Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents

Sexually Transmitted Diseases

Volumn 39, Issue 4, 2012, Pages 300-305

  Sudenga, Staci L ^a   Kempf, Mirjam Colette ^a   McGwin, Gerald ^a   Wilson, Craig M ^a   Hook, Edward W ^b   Shrestha, Sadeep ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; ALCOHOLISM; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; RACE; RISK; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEROLOGY; SEXUALITY; VIRUS LOAD;

ADOLESCENT; CD4 LYMPHOCYTE COUNT; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; INCIDENCE; MALE; ODDS RATIO; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; VIRAL LOAD;

EID: 84858706502     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318244a90f     Document Type: Article

References (28)

1. Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ 2008; 86:805-812, A.
2. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years-United States, 2005-2008. MMWR Morb Mortal Wkly Rep 2010; 59:456-459.
3. Szucs TD, Berger K, Fisman DN, et al. The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches. BMC Infect Dis 2001; 1:5.
4. Gupta R, Warren T, Wald A. Genital herpes. Lancet 2007; 370: 2127-2137. (Pubitemid 350296304)
5. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73-83. (Pubitemid 41818117)
6. Tassiopoulos KK, Seage G III, Sam N, et al. Predictors of herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania. J Infect Dis 2007; 195:493-501. (Pubitemid 46214391)
7. Mahiane SG, Legeai C, Taljaard D, et al. Transmission probabilities of HIV and herpes simplex virus type 2, effect of male circumcision and interaction: A longitudinal study in a township of South Africa. AIDS 2009; 23:377-383.
8. del Mar Pujades Rodriguez M, Obasi A, Mosha F, et al. Herpes simplex virus type 2 infection increases HIV incidence: A prospective study in rural Tanzania. AIDS 2002; 16:451-462. (Pubitemid 34165378)
9. Mertz KJ, Trees D, Levine WC, et al. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. J Infect Dis 1998; 178:1795-1798. (Pubitemid 28558157)
10. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008; 358:1560-1571. (Pubitemid 351519816)
11. Delany-Moretlwe S, Lingappa JR, Celum C. New insights on interactions between HIV-1 and HSV-2. Curr Infect Dis Rep 2009; 11:135-142.
12. Reynolds SJ, Risbud AR, Shepherd ME, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003; 187:1513-1521. (Pubitemid 36578957)
13. Rogers AS, Futterman DK, Moscicki AB, et al. The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, methods, and selected characteristics of participants. J Adolesc Health 1998; 22:300-311. (Pubitemid 28163251)
14. Wilson CM, Houser J, Partlow C, et al. The REACH (Reaching for Excellence in Adolescent Care and Health) project: Study design, methods, and population profile. J Adolesc Health 2001; 29:8-18. (Pubitemid 32799155)
15. Schmid DS, Brown DR, Nisenbaum R, et al. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol 1999; 37:376-379. (Pubitemid 29056408)
16. Moscicki AB, Ellenberg JH, Farhat S, et al. Persistence of human papillomavirus infection in HIV-infected and-uninfected adolescent girls: Risk factors and differences, by phylogenetic type. J Infect Dis 2004;190:37-45. (Pubitemid 38858402)
17. Tsai CS, Shepherd BE, Vermund SH. Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents. Am J Obstet Gynecol 2009; 200:38 e1-38 e8.
18. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296:964-973. (Pubitemid 44285373)
19. Leone P, Fleming DT, Gilsenan AW, et al. Seroprevalence of herpes simplex virus-2 in suburban primary care offices in the United States. Sex Transm Dis 2004; 31:311-316. (Pubitemid 38542662)
20. Gottlieb SL, Douglas JM Jr, Foster M, et al. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis 2004; 190:1059-1067. (Pubitemid 39186791)
21. Gallo MF, Warner L, Macaluso M, et al. Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic. Sex Transmit Dis 2008; 35:679-685.
22. Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005; 143:707-713.
23. Cachay ER, Frost SD, Poon AF, et al. Herpes simplex virus type 2 acquisition during recent HIV infection does not influence plasma HIV levels. J Acquir Immun Defic Syndr 2008;47:592-596. (Pubitemid 351442015)
24. Tobian AA, Charvat B, Ssempijja V, et al. Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda J Infect Dis 2009; 199: 945-949.
25. Shafer LA, Nsubuga RN, White R, et al. Antiretroviral therapy and sexual behavior in Uganda: a cohort study. AIDS 2011; 25:671-678.
26. Park WB, Jang HC, Kim SH, et al. Effect of highly active antiretroviral therapy on incidence of early syphilis in HIVinfected patients. Sex Transm Dis 2008; 35:304-306. (Pubitemid 351619535)
27. Scheer S, Chu PL, Klausner JD, et al. Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet 2001; 357:432-435. (Pubitemid 32156142)
28. Hoots BE, Hudgens MG, Cole SR, et al. Lack of association of herpes simplex virus type 2 seropositivity with the progression of HIV infection in the HERS cohort. Am J Epidemiol 2011; 173:837-844.